$1.52
-0.02-1.30%
Pre-Market: 4:16 PM EDT
Comments
Loading...
Can Fite Biofarma Earnings Estimates, EPS & Revenue | AMEX:CANF | Benzinga
Can Fite Biofarma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS Estimate
$-0.410
Quarterly Revenue Estimate
$150.00K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$667.00K
Analyze the earnings history of Can Fite Biofarma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CANF | Can Fite Biofarma | — | -$0.41 | — | — | — | $150.00K | — | — | 04/08/2025 | Get Alert |
| CANF | Can Fite Biofarma | $0.00 | -$0.40 | $0.00 | 100.00% | $392.00K | $150.00K | $316.00K | 110.67% | 08/29/2024 | Get Alert |
| CANF | Can Fite Biofarma | -$1.11 | -$0.26 | -$0.01 | 96.15% | $197.00K | $100.00K | $155.00K | 55.00% | 03/28/2024 | Get Alert |
| CANF | Can Fite Biofarma | -$0.01 | -$0.44 | -$0.43 | 2.27% | $613.00K | $100.00K | $196.00K | 96.00% | 11/30/2023 | Get Alert |
| CANF | Can Fite Biofarma | -$0.80 | -$0.42 | -$0.40 | 4.76% | $204.00K | $100.00K | $196.00K | 9600.00% | 08/31/2023 | Get Alert |
| CANF | Can Fite Biofarma | $0.00 | -$1.52 | -$0.65 | 57.24% | $205.00K | — | $196.00K | — | 06/01/2023 | Get Alert |
| CANF | Can Fite Biofarma | -$0.10 | -$0.98 | -$1.11 | -13.27% | $204.00K | $330.00K | $197.00K | -40.30% | 03/30/2023 | Get Alert |
| CANF | Can Fite Biofarma | -$0.10 | -$1.10 | -$0.10 | 90.91% | $251.00K | $200.00K | $204.00K | 2.00% | 11/25/2022 | Get Alert |
| CANF | Can Fite Biofarma | -$0.10 | -$1.00 | -$0.80 | 20.00% | $250.00K | — | $204.00K | — | 08/25/2022 | Get Alert |
| CANF | Can Fite Biofarma | $0.00 | -$1.40 | $0.00 | 100.00% | $148.00K | $200.00K | $205.00K | 2.50% | 05/26/2022 | Get Alert |
| CANF | Can Fite Biofarma | -$0.10 | -$1.80 | -$0.10 | 94.44% | $150.00K | $250.00K | $204.00K | -18.40% | 03/24/2022 | Get Alert |
| CANF | Can Fite Biofarma | $0.10 | -$0.90 | -$0.20 | 77.78% | $211.00K | $150.00K | $251.00K | 67.33% | 11/26/2021 | Get Alert |
| CANF | Can Fite Biofarma | -$0.10 | -$1.00 | -$0.10 | 90.00% | $204.00K | $120.00K | $250.00K | 108.33% | 08/26/2021 | Get Alert |
| CANF | Can Fite Biofarma | -$0.30 | -$1.60 | $0.00 | 100.00% | $198.00K | $200.00K | $148.00K | -26.00% | 05/27/2021 | Get Alert |
| CANF | Can Fite Biofarma | $0.00 | — | -$0.10 | — | $192.00K | — | $150.00K | — | 03/25/2021 | Get Alert |
| CANF | Can Fite Biofarma | -$0.30 | -$2.40 | $0.10 | 104.17% | $1.15M | $250.00K | $211.00K | -15.60% | 11/30/2020 | Get Alert |
| CANF | Can Fite Biofarma | -$0.40 | -$3.30 | -$0.10 | 96.97% | $389.00K | $250.00K | $204.00K | -18.40% | 08/27/2020 | Get Alert |
| CANF | Can Fite Biofarma | -$0.40 | -$6.60 | -$0.30 | 95.45% | $299.00K | $1.18M | $198.00K | -83.22% | 06/01/2020 | Get Alert |
Can Fite Biofarma (CANF) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| H1 | 2024-08-29 | $0 | $-0.40 | 100.0 % |
| Q4 | 2024-03-28 | $-0.01 | $-0.26 | 96.2 % |
| Q3 | 2023-11-30 | $-0.43 | $-0.44 | 2.27 % |
| Q2 | 2023-08-31 | $-0.40 | $-0.42 | 4.76 % |
Can Fite Biofarma (CANF) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| H1 | 2024-08-29 | $316.00K | $150.00K | 110.7 % |
| Q4 | 2024-03-28 | $155.00K | $100.00K | 55.0 % |
| Q3 | 2023-11-30 | $196.00K | $100.00K | 96.0 % |
| Q2 | 2023-08-31 | $196.00K | $100.00K | 9600.0 % |
FAQ
When is Can Fite Biofarma (AMEX:CANF) reporting earnings?
Can Fite Biofarma (CANF) is scheduled to report earnings on April 8, 2025. The last reported earnings were for reported on August 29, 2024 for H1.
What were the latest earnings per share (EPS) for Can Fite Biofarma (AMEX:CANF)?
The Actual EPS was $0.00, which beat the estimate of $-0.40.
What were Can Fite Biofarma’s (AMEX:CANF) revenues?
The Actual Revenue was $316K, which beat the estimate of $150K.
Browse earnings estimates, EPS, and revenue on all stocks.